Quest Company Equity Multiplier from 2010 to 2025

DGX Stock  USD 167.33  1.33  0.80%   
Quest Diagnostics Company Equity Multiplier yearly trend continues to be fairly stable with very little volatility. Company Equity Multiplier is likely to outpace its year average in 2025. During the period from 2010 to 2025, Quest Diagnostics Company Equity Multiplier regression line of annual values had r-squared of  0.06 and arithmetic mean of  2.26. View All Fundamentals
 
Company Equity Multiplier  
First Reported
2010-12-31
Previous Quarter
2.38315137
Current Value
2.49
Quarterly Volatility
0.15791253
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Quest Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 274.7 M, Interest Expense of 237.3 M or Selling General Administrative of 1.5 B, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0208 or PTB Ratio of 2.99. Quest financial statements analysis is a perfect complement when working with Quest Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Quest Diagnostics Correlation against competitors.

Latest Quest Diagnostics' Company Equity Multiplier Growth Pattern

Below is the plot of the Company Equity Multiplier of Quest Diagnostics Incorporated over the last few years. It is Quest Diagnostics' Company Equity Multiplier historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quest Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Company Equity Multiplier10 Years Trend
Pretty Stable
   Company Equity Multiplier   
       Timeline  

Quest Company Equity Multiplier Regression Statistics

Arithmetic Mean2.26
Geometric Mean2.26
Coefficient Of Variation6.98
Mean Deviation0.12
Median2.23
Standard Deviation0.16
Sample Variance0.02
Range0.5144
R-Value(0.24)
Mean Square Error0.03
R-Squared0.06
Significance0.37
Slope(0.01)
Total Sum of Squares0.37

Quest Company Equity Multiplier History

2025 2.49
2024 2.38
2023 2.22
2020 2.08
2019 2.28
2018 2.11

About Quest Diagnostics Financial Statements

Quest Diagnostics investors use historical fundamental indicators, such as Quest Diagnostics' Company Equity Multiplier, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quest Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Company Equity Multiplier 2.38  2.49 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.